ALB and metastatic melanoma: Hersh E.M. et al. (2010) aimed to determine the antitumor activity of the formulation ABI-007 (nanoparticle albumin-bound–paclitaxel) in patients with inoperable locally recurrent or metastatic melanoma and to determine the safety and tolerability of this drug [81].